Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nonalcoholic steatohepatitis
Marketing
Madrigal, eyeing a NASH drug launch, nabs Dupixent vet as CCO
Madrigal Pharmaceuticals has hired Carole Huntsman as its new CCO to help the biotech navigate a new and potentially tricky launch in NASH.
Ben Adams
Nov 13, 2023 9:30am
FDA calls AdComm for Intercept's NASH drug application
Mar 10, 2023 11:18am
89bio gets green light to take liquid NASH prospect into phase 2
Apr 6, 2021 8:10am
Intercept cuts 25% of workforce after NASH rejection from FDA
Sep 1, 2020 4:10pm
Noninvasive tests can advance NASH diagnostics: analysis
Nov 12, 2019 11:16am
Intercept slides on FDA safety flag for Ocaliva
Sep 22, 2017 10:13am
